Quantitative Assessment of the Effect of Hepatic Lipase Gene Polymorphism on the Risk of Coronary Heart Disease

Lloyd-Jones, 2009, Heart disease and stroke statistics–2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 119, e21, 10.1161/CIRCULATIONAHA.108.191261 Stamler, 1986, Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT), JAMA, 256, 2823, 10.1001/jama.256.20.2823 Krauss, 1995, Dense low density lipoproteins and coronary artery disease, Am J Cardiol, 75, 53B, 10.1016/0002-9149(95)80012-H Superko, 1996, What can we learn about dense low density lipoprotein and lipoprotein particles from clinical trials?, Curr Opin Lipidol, 7, 363, 10.1097/00041433-199612000-00004 Campos, 1995, Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses, J Lipid Res, 36, 462, 10.1016/S0022-2275(20)39880-1 Zambon, 1993, Effect of hepatic lipase on LDL in normal men and those with coronary artery disease, Arterioscler Thromb, 13, 147, 10.1161/01.ATV.13.2.147 Tan, 1995, Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance, Atherosclerosis, 113, 273, 10.1016/0021-9150(94)05454-Q Santamarina-Fojo, 1998, The role of hepatic lipase in lipoprotein metabolism and atherosclerosis, Curr Opin Lipidol, 9, 211, 10.1097/00041433-199806000-00005 Guerra, 1997, A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol, Proc Natl Acad Sci USA, 94, 4532, 10.1073/pnas.94.9.4532 Tahvanainen, 1998, Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators, J Clin Invest, 101, 956, 10.1172/JCI1144 Shohet, 1999, Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-concentrations, Arterioscler Thromb Vasc Biol, 19, 1975, 10.1161/01.ATV.19.8.1975 Jansen, 2002, Hepatic lipase: a pro- or anti-atherogenic protein?, J Lipid Res, 43, 1352e62, 10.1194/jlr.R200008-JLR200 Deeb, 2000, The C−514T polymorphism in the human hepatic lipase gene promoter diminishes its activity, J Lipid Res, 41, 155, 10.1016/S0022-2275(20)32086-1 Botma, 2001, Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by upstream stimulatory factor, Atherosclerosis, 154, 625, 10.1016/S0021-9150(00)00478-0 Zhao, 2006, The −250G– >A polymorphism in the human hepatic lipase gene promoter affects blood lipids in Chinese, Clin Chim Acta, 365, 149, 10.1016/j.cca.2005.08.013 Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Mantel, 1959, Statistical aspects of the analysis of data from retrospective studies of disease, J Natl Cancer Inst, 22, 719 Woolf, 1955, On estimating the relation between blood group and disease, Ann Hum Genet, 19, 251, 10.1111/j.1469-1809.1955.tb01348.x Hedrick, 1987, Gametic disequilibrium measures: proceed with caution, Genetics, 117, 331, 10.1093/genetics/117.2.331 Jansen, 1997, Common C-to-T substitution at position −480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients, Arterioscler Thromb Vasc Biol, 17, 2837, 10.1161/01.ATV.17.11.2837 Zambon, 1998, Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol, Arterioscler Thromb Vasc Biol, 18, 1723, 10.1161/01.ATV.18.11.1723 Hong, 2000, Genetic variations of the hepatic lipase gene in Korean patients with coronary artery disease, Clin Biochem, 33, 291, 10.1016/S0009-9120(00)00077-1 Ji, 2002, Hepatic lipase gene −514 C/T polymorphism and premature coronary heart disease, J Cardiovasc Risk, 9, 105, 10.1097/00043798-200204000-00006 Hokanson, 2003, Effects of the hepatic lipase gene and physical activity on coronary heart disease risk, Am J Epidemiol, 158, 836, 10.1093/aje/kwg230 Whiting, 2005, Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease, Am Heart J, 150, 243, 10.1016/j.ahj.2004.08.034 Fan, 2004, Hepatic lipase C-480T polymorphism modifies the effect of HDL cholesterol on the risk of acute myocardial infarction in men: a prospective population based study, J Med Genet, 41, e28, 10.1136/jmg.2003.010652 de Andrade, 2004, Association between −250G/A polymorphism of the hepatic lipase gene promoter and coronary artery disease and HDL-C levels in a Southern Brazilian population, Clin Genet, 65, 390, 10.1111/j.0009-9163.2004.00243.x Zhang, 2006, Genetic variation in the hepatic lipase gene and the risk of coronary heart disease among US diabetic men: potential interaction with obesity, Diabetologia, 49, 1552, 10.1007/s00125-006-0235-2 Fan, 2007, Age-dependent association between hepatic lipase gene C-480T polymorphism and the risk of pre-hospital sudden cardiac death: the Helsinki Sudden Death Study, Atherosclerosis, 192, 421, 10.1016/j.atherosclerosis.2006.05.028 van Acker, 2008, High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants, Atherosclerosis, 200, 161, 10.1016/j.atherosclerosis.2007.11.019 Johannsen, 2009, Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease, J Clin Endocrinol Metab, 94, 1264, 10.1210/jc.2008-1342 Baylin, 2009, Association between hepatic lipase −514 C/T promoter polymorphism and myocardial infarction is modified by history of hypercholesterolemia and waist circumference, Nutr Metab Cardiovasc Dis Gündoğdu, 2008, Association between −514C– >T polymorphism of the hepatic lipase gene and coronary artery disease in a Turkish population, Acta Cardiol, 63, 197, 10.2143/AC.63.2.2029528 Wei, 2009, Association of the hepatic lipase gene −250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease, Chin J Med Genet, 1, 219 Isaacs, 2004, The −514 C→T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis, J Clin Endocrinol Metab, 89, 3858, 10.1210/jc.2004-0188 Cohen, 1994, Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels, J Clin Invest, 94, 2377, 10.1172/JCI117603 Deeb, 2003, Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet, J Lipid Res, 44, 1279, 10.1194/jlr.R200017-JLR200 Applebaum-Bowden, 1995, Lipases and lecithin: cholesterol acyltransferase in the control of lipoprotein metabolism, Curr Opin Lipidol, 6, 130, 10.1097/00041433-199506000-00004 Kathiresan, 2008, Polymorphisms associated with cholesterol and risk of cardiovascular events, N Engl J Med, 358, 1240, 10.1056/NEJMoa0706728 Roest, 2000, Homozygosity for 807 T polymorphism in alpha (2) subunit of platelet alpha (2)beta (1) is associated with increased risk of cardiovascular mortality in high-risk women, Circulation, 102, 1645, 10.1161/01.CIR.102.14.1645